• en
  • it
  • de
  • Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and scalable supply of CBD, from clinical needs to full-scale commercial operations. “As a long-standing supplier of specialized […]

    HQ’s New Location: A move we’ve been waiting

    Pharmazell Group headquarters recently moved into a bright, collaborative office – a move we’ve been waiting for. The new office in Raubling is an open concept with design features that encourage more interaction and informal conversation. Staff are enjoying the common areas as a new space for thinking and working. We would be happy to […]